This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Industrial Technology Research Institute. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: Mei-Hsuan Tsai: Innovator in Drug Conjugates
Introduction
Mei-Hsuan Tsai is a notable inventor based in Nantou, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds and drug conjugates. With a total of 2 patents, his work is paving the way for advancements in drug delivery systems.
Latest Patents
Mei-Hsuan Tsai's latest patents focus on compounds, linker-drugs, and ligand-drug conjugates. One of his patents describes a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof. In this formula, R1, R2, and R3 can be various chemical groups, including hydrogen, amino, nitro, halogen, hydroxyl, and more. The innovation lies in the provision that at least one of R1 and R3 must be an amino group. This patent also includes a linker-drug and a ligand-drug conjugate that incorporates the compound.
Career Highlights
Mei-Hsuan Tsai is affiliated with the Industrial Technology Research Institute, where he conducts his research and development. His work is characterized by a strong focus on innovative drug formulations that enhance therapeutic efficacy.
Collaborations
Mei-Hsuan collaborates with On Lee, a talented woman in the field, contributing to the advancement of their shared research goals.
Conclusion
Mei-Hsuan Tsai's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in drug conjugates. His work continues to influence the development of new therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile